[1]JaresP,ColomerD,CampoE.Geneticandmolecularpathogenesisofmantlecelllymphoma:perspectivesfornewtargetedtherapeutics[J].NatRevCancer，，7：–.

　　[2]Rodriguez-JustoM,HuangY,YeH，etal.CyclinD1-positivediffuselargeB-celllymphoma[J].Histopathology，,52：–.DOI：10./j.–...x.

　　[3]OkCY,Xu-MonetteZY,TzankovA,etal.PrevalenceandclinicalimplicationsofcyclinD1expressionindiffuselargeB-celllymphomatreatedwithimmunochemotherapy:areportfromtheInternationalDLBCLRituximab-CHOPConsortiumProgram[J].Cancer，，：–.DOI:10./cncr..

　　[4]Vela-ChavezT,AdamP,KremerM,etal.CyclinD1positivediffuselargeB-celllymphomaisapost-germinalcenter-typelymphomawithoutalterationsintheCCND1genelocus[J].LeukLymphoma,,52：–.DOI:10./...

　　[5]LucioniM,NovaraF,RiboniR，etal.CD5diffuselargeB-celllymphomawithpeculiarcyclinD1＋phenotype.Pathologicandmolecularcharacterizationofasinglecase[J].HumPathol,,42：4–8.DOI:10./j.humpath..11..

　　[6]EhingerM,LinderothJ,ChristenssonB,etal.AsubsetofCD5-diffuselargeB-celllymphomasexpressesnuclearcyclinD1withaberrationsattheCCND1locus[J].AmJClinPathol，,：–.DOI:10./42CQ0HU7XEY9QMQX.

　　[7]RomagueraJE,FayadLE,FengL,etal.Ten-yearfollow-upafterintensechemoimmunotherapywithRituximab-HyperCVADalternatingwithRituximab-highdosemethotrexate/cytarabineandwithoutstemcelltransplantationinpatientswithuntreatedaggressivemantlecelllymphoma[J].BrJHaematol，,：–.DOI:10./j.–...x.